Top 7 Exercises For People With Flat Foot

Updated Mar 16, 2025 | 11:00 PM IST

SummaryThanks to exercises, there are ways you can current your fallen arch. If not correct, these exercises could help you to relieve some pain and correct your posture. Most of these exercises focus on raising, strengthening, and lengthening your arches.
Flat foot exercises

Credits: Freepik

Flat feet or pes planus are commonly known as fallen or collapsed arches. While it is a common condition, but it can be painful to live with it. This means that 30% of the world's population live with the same conditions, while symptoms show in 1 in 10. The symptoms usually could be pain, stress and imbalances in other parts of your body. Since fallen arches cause your body to become imbalanced, it may be difficult to workout, or perform day to day activities without feeling excruciating pain. This could often lead to injuries, obesity, and arthritis. Aging, genetics, and pregnancy could also contribute to flat feet.

However, thanks to exercises, there are ways you can current your fallen arch. If not correct, these exercises could help you to relieve some pain and correct your posture. Most of these exercises focus on raising, strengthening, and lengthening your arches.

So, let's have a look at these exercises that you can do even with your flat feet, so you no longer feel left out when there is a need to perform physical activities:

Heel Stretches

  • Start with standing with your hands resting on a wall or a chair
  • Keep one leg forward
  • Press both heels on the floor
  • With your spine straight, bend your front leg and push yourself into the wall
  • Feel the stretch at your back leg
  • Hold this position for 30 seconds
  • Do each leg 4 times

Tennis Ball Rolls

  • You can get a chair for this and put a tennis or a golf ball under your right foot
  • Now, roll the ball under your foot and focus on the arch
  • Do this for 2 to 3 minutes, then repeat the same with the opposite leg

Arch Lifts

  • Stand with your feet directly beneath your hips
  • Keep your toes firmly on the floor as you shift your weight to the outer edges of your feet, lifting your arches as high as possible
  • Slowly lower your feet back down. This exercise targets the muscles that help lift and supinate your arches
  • Perform 2–3 sets of 10–15 repetitions

Calf Raises

  • Stand and raise your heels as high as you can
  • Use a chair or wall for balance if needed
  • Hold the elevated position for 5 seconds, then slowly lower back down to the floor
  • Complete 2–3 sets of 15–20 repetitions
  • Afterward, hold the raised position and pulse up and down for 30 seconds

Stair Arch Raises

  • Stand on a step with your left foot placed higher than your right foot
  • Use your left foot for stability as you lower your right foot, letting your heel drop below the step
  • Gradually raise your right heel as high as possible, concentrating on strengthening your arch
  • As you lift, rotate your arch inward while allowing your knee and calf to turn slightly outward, which will raise your arch even further
  • Slowly return to the starting position
  • Complete 2–3 sets of 10–15 repetitions on each side

Towel Curls

  • Sit in a chair with a towel placed under your feet
  • Press your heels into the floor as you curl your toes to scrunch the towel toward you
  • Focus on pressing your toes into your foot, holding the position for a few seconds before releasing
  • Ensure that the ball of your foot stays in contact with the floor or towel, maintaining awareness of the arch as it strengthens
  • Complete 2–3 sets of 10–15 repetitions

Toe Raises

For a variation, you can try performing this exercise while in standing yoga poses like Tree Pose, Standing Forward Bend, or Standing Split.

  • While standing, press your right big toe into the floor and lift the other four toes
  • Next, press the four toes into the floor and lift your big toe
  • Repeat each movement 5–10 times, holding each lift for 5 seconds
  • Then switch and repeat the exercise on your left foot

End of Article

How Keep The Weight Off After GLP-1 Treatment: Lancet Study Compares 5 Weight Maintenance Strategies

Updated Nov 16, 2026 | 08:00 PM IST

SummaryA recent study published in The Lancet's eClinicalMedicine compared five weight loss maintenance strategies after stopping or changing original GLP-1 treatment.
How Keep The Weight Off After GLP-1 Treatment: Lancet Study Compares 5 Weight Maintenance Strategies

Credit: AI-generated image

What happens when people stop taking GLP-1 weight-loss injections like Ozempic, Wegovy or Mounjaro? Do they regain weight, switch to another medication or consider bariatric surgery?

A new study published in The Lancet's eClinicalMedicine examined that what people do after their initial GLP-1 treatment can make a significant difference in their long-term weight outcomes.

Maintaining Weight After GLP-1 Treatment

Also read: World Diabetes Day: Why Some Diabetes Patients May Not Be Suitable For GLP-1 Treatment, Experts Explain

Researchers at Cleveland Clinic examined health records from 20,486 patients who had taken semaglutide or tirzepatide injections for at least three months.

They compared five weight loss maintenance over a two-year period: continuing the original weight loss medication, switching between the two drugs, moving to another obesity medication, undergoing bariatric surgery or stopping treatment altogether without pursuing another option.

After two years, the average weight reductions were:

  • Bariatric surgery: Approximately 28% of body weight.
  • Switching between semaglutide and tirzepatide: 16%.
  • Continuing the original GLP-1 medication: Nearly 11%.
  • Switching to another obesity medication: Approximately 8%.
  • Stopping treatment without further intervention: Approximately 4%.

These results indicate that discontinuing GLP-1 treatment does not mean all the lost weight will come back. But patients who stopped treatment without another medical or surgical intervention experienced the lowest success in keeping the weight off.

The study also found that the outcomes of switching depended on which medication patients were taking initially. Those who moved from semaglutide to tirzepatide lost more weight than those who continued semaglutide. However, among people initially taking tirzepatide, remaining on the medication led to greater weight loss than switching to semaglutide.

What Happens To Blood Sugar And Blood Pressure After Stopping?

Also read: Stopping Ozempic or Wegovy May Double Your Risk Of Heart Attack, Death

Not just weight loss, the findings also covered metabolic outcomes as patients with existing health conditions also showed significant differences.

Among participants with type 2 diabetes, bariatric surgery proved to drive major improvement in HbA1c. This was followed by switching between semaglutide and tirzepatide, continuing the original medication and moving to another obesity drug.

Patients with hypertension who continued treatment also experienced greater reductions in blood pressure than those who stopped.

Those who discontinued treatment without another intervention showed the smallest improvements in blood glucose control and blood pressure.

Why Do People Stop Taking Weight-Loss Injections?

GLP-1 medications have become increasingly popular for managing diabetes and combating obesity, but long-term treatment can be difficult for some patients to maintain.

Cost, insurance and side effects are among the reasons why people may discontinue these medicines. Gastrointestinal symptoms like nausea, vomiting, diarrhoea and constipation can also affect adherence to treatment.

People who cannot continue their original medication, and are considering switching to another treatment or considering bariatric surgery should discuss their options with their healthcare providers.

Lead author Hamlet Gasoyan, a researcher at Cleveland Clinic's Center for Value-Based Care Research, said, “The encouraging news is that, for patients who need to stop their injectable GLP-1 medication, it does not mean that their obesity treatment journey has to end.”

Co-author Ali Aminian, director of Cleveland Clinic's Bariatric and Metabolic Institute, added, “When a patient stops a GLP-1 medication, the most important question is what comes next.”

He noted that patients who stopped all treatment had the least weight loss while those who moved on to another therapy, particularly bariatric surgery, did significantly better.

End of Article

Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI

Updated Nov 12, 2026 | 07:17 AM IST

SummaryA recent study found that body mass index (BMI) could inaccurately diagnose people with obesity. It suggested that overweight people should be classified into two categories: pre-clinical obesity and clinical obesity.
Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI

Credit: iStock

For years, body mass index (BMI) has been a key health marker to track obesity. But a recent study suggests that not everyone classified as obese based on their BMI may have obesity-related health problems. Researchers say just considering BMI alone may lead to incorrect diagnosis in some people while overlooking others with excess body fat and related health risks.

The international study, involving more than 844,000 adults across China, the UK, the US and Spain, supports a different approach that considers body fat distribution, waist measurement and the impact of excess fat on organ function.

Researchers propose distinguishing between two categories: pre-clinical obesity, in which excess body fat increases health risks but has not impaired organ function, and clinical obesity, in which excess fat is already affecting the body's ability to function.

BMI Alone Not Enough To Diagnose Obesity

Also read: Why WHO Wants To Use Smartwatches To Track Physical Activity & Sedentary Behaviour At A Population Level?

BMI is calculated by dividing a person's weight in kilograms by their height in metres squared. It is used to classify people as underweight, normal weight, overweight or obese.

However, BMI does not directly measure body fat or show where fat is distributed. It also cannot distinguish between fat and muscle mass. Consequently, two people with the same BMI may have very different body compositions and health risks.

The researchers found that adding waist circumference and waist-to-height ratio to BMI helped identify people whose excess body fat might otherwise be missed.

The analysis suggested that BMI alone missed obesity level body fat in up to 8.6% of participants, while incorrectly classifying up to 3.1% as having obesity in the study groups.

Professor Francesco Rubino, senior author of the study and Chair of Metabolic and Bariatric Surgery at King's College London, said, “Body mass index alone cannot tell us whether someone is already ill or at risk of illness, or what care they need, leaving people vulnerable to both undertreatment and overtreatment.”

Difference Between Clinical And Pre-Clinical Obesity

Also read: Loud Snoring Is Not Always Harmless: Sleep Apnoea can Become a Stroke-Risk Concern

The researchers used a framework proposed by the Lancet Diabetes and Endocrinology Commission in 2025. It separates obesity into two categories based on whether excess body fat has affected a person's health.

  • Pre-clinical obesity: A person has excess body fat that increases their risk of developing health problems, but their organ function and everyday activities remain unaffected.
  • Clinical obesity: Excess body fat has impaired organ function or affected a person's ability to perform daily activities. It is considered an active disease that requires clinical assessment.

The study estimated that only around 23% to 31% of people classified as having obesity across the four study populations had clinical obesity. This represented approximately 5.6% to 10.9% of the overall adult populations studied.

When Do People With Pre-Clinical Obesity Develop Health Problems?

The researchers followed participants over time to examine how often pre-clinical obesity progressed to clinical obesity.

They found that approximately 77% to 91% of people classified as having pre-clinical obesity did not progress to clinical obesity over 10 years. However, progression rates differed across the study populations.

Clinical obesity was linked with a higher risk of death while pre-clinical obesity had a more modest increase in risk.

Professor Rubino said, “Preclinical obesity should therefore be neither treated automatically as active disease nor dismissed as harmless. Some people may need preventive treatment, but its intensity should match their individual risk.”

The findings do not mean that people with pre-clinical obesity should ignore excess body fat. Rather, they highlight the importance of assessing individual health risks instead of making treatment decisions based on BMI alone.

People with excess body fat may still benefit from lifestyle hanges, treatment and preventive care even if they have not developed organ dysfunction.

End of Article

Why WHO Wants To Use Smartwatches To Track Physical Activity & Sedentary Behaviour At A Population Level?

Updated Nov 10, 2026 | 12:00 AM IST

SummaryThe World Health Organization (WHO) wants to standardise the manufacturing of smartwatches and fitness trackers so it can harvest data about physical activity and sedentary behaviour on a population level.
Why WHO Wants To Use Smartwatches To Track Physical Activity & Sedentary Behaviour At A Population Level?

Credit: AI

Smartwatches and fitness trackers are widely used for counting daily steps and tracking workouts by millions. But the World Health Organization (WHO) is now seeking to task these wearables with bigger responsibilities. The global health body has issued proposals for wearable devices that could help countries measure physical activity and sedentary behaviour across populations.

In a notice published on November 8, WHO invited researchers, health authorities, technology developers and other stakeholders to review a draft Target Product Profile (TPP) for wearable devices worn on wrists. The aim is to ascertain what these devices should be capable of measuring before they are incorporated into national and subnational public health monitoring systems.

The proposal will remain open until December 6, 2026. WHO will use the feedback to revise and finalise the document and inform future implementation guidance.

WHO Want To Use Smartwatches For Public Health Monitoring

Also read: Lancet Study Says Obesity Drug Mazdutide Shows 18% Weight Loss In 32 Weeks: How Does It Compare To Wegovy?

Physical inactivity is a major risk factor for non-communicable diseases, including cardiovascular disease, type 2 diabetes and certain cancers. Sedentary behaviour, which involves spending prolonged periods sitting is also the cause of various adverse health outcomes.

Countries currently rely heavily on surveys to understand how physically active people are. However, these often depend on people reporting their own activity, which can lead to inaccurate data.

Wearable devices could provide a more objective way to collect information over a certain period of time. Instead of relying entirely on questionnaires, health authorities could use data from these devices to understand how much people move, how long they remain sedentary and how activity patterns vary across different population groups.

WHO says wearable technology could complement existing surveillance methods as countries work towards improving global physical activity targets.

WHO's Proposed Standards

Also read: Weight Loss Without Extreme Diets: What Sustainable Medical Weight Management Looks Like

The draft TPP outlines minimum specifications for smartwatches intended for population-level monitoring. It considers what makes a device suitable for collecting data across different populations.

The proposed framework covers:

  • Measurement capabilities: What physical activity and sedentary behaviour indicators a device should be able to capture.
  • Technical specifications: The minimum and additional features required for devices to be suitable for public health surveillance.
  • Data access: How information can be retrieved, processed and used by health monitoring systems.
  • Implementation: Practical considerations involved in deploying devices across communities and integrating them into existing surveillance programmes.
  • Scalability and sustainability: Whether the technology can be used consistently across countries with different resources and technical capacities.

WHO is interested in feedback on whether the specifications proposed are practical and relevant to countries with limited resources.

Why Can't Countries Use Existing Smartwatches?

Although such wearables are widely available, their measurements are not interchangeable. Different manufacturers use different sensors, algorithms and methods to calculate steps, activity levels and sedentary time. As a result, two devices worn by the same person may produce different estimates.

A systematic review published in npj Digital Medicine in January 2026 examined 82 studies evaluating Apple Watch measurements across 14 health metrics. It found that measurement accuracy varied depending on the metric and testing conditions. While heart-rate measurements showed good overall agreement, step counts had moderate accuracy and energy expenditure data was inconsistent too.

This illustrates the need for standardisation. If countries use different devices and measurement methods, comparing physical activity data across populations becomes needlessly challenging.

WHO's proposed framework is intended to address these differences by identifying the device characteristics and protocols needed for consistent data collection.

Cost, access, privacy and digital literacy remain important challenges when it comes to implementing WHO's proposal. People without smartphones, reliable internet access or the ability to buy wearable devices could be underrepresented.

There are also questions about how personal movement data would be stored, shared and protected. Governments would need clear safeguards to ensure that participation is voluntary, data is handled responsibly and findings represent the wider population.

End of Article